Intuitive Surgical (NASDAQ: ISRG) revenue
Intuitive Surgical reported revenue of $10,065m for fiscal 2025, 20.5% more than in fiscal 2024 ($8,352m). Since fiscal 2016 its revenue has grown by 271.9%, an average growth of 15.7% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $10,065m | +20.5% | $2,946m | 29.3% |
| 2024 | $8,352m | +17.2% | $2,349m | 28.1% |
| 2023 | $7,124m | +14.5% | $1,767m | 24.8% |
| 2022 | $6,222m | +9.0% | $1,577m | 25.3% |
| 2021 | $5,710m | +31.0% | $1,821m | 31.9% |
| 2020 | $4,358m | −2.7% | $1,050m | 24.1% |
| 2019 | $4,479m | +20.3% | $1,375m | 30.7% |
| 2018 | $3,724m | +18.7% | $1,199m | 32.2% |
| 2017 | $3,138m | +16.0% | $1,063m | 33.9% |
| 2016 | $2,707m | — | $949.7m | 35.1% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the revenue of Intuitive Surgical
- How much revenue did Intuitive Surgical make in fiscal 2025?
- Intuitive Surgical reported revenue of $10,065m for fiscal 2025, compared with $8,352m in fiscal 2024.
- How much has the revenue of Intuitive Surgical grown?
- Between fiscal 2016 and fiscal 2025 it went from $2,707m to $10,065m: 271.9% more, an average growth of 15.7% a year.
- What was the best year for revenue at Intuitive Surgical?
- Of its last 10 fiscal years, fiscal 2025, with $10,065m.
- Where do the figures for Intuitive Surgical come from?
- From the annual report (Form 10-K) that Intuitive Surgical files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Intuitive Surgical files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Intuitive Surgical: the Intuitive Surgical page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.